A Breakthrough in Hanmi Life Sciences, GeneAKG® Sets a New Global Benchmark in Anti-Aging with Proprietary Patented Technology
Anyang-si, Gyeonggi-do, Korea, Oct. 22, 2026 (GLOBE NEWSWIRE) -- The global anti-aging industry is undergoing a profound transformation. IEONA GeneAKG®, developed by the Hanmi Life Sciences team under NEXTEYE Group (Stock Code: 137940.KQ), is pioneering a shift from single-ingredient supplementation to systematic metabolic intervention through its world-first patented technology, three-dimensional synergistic formulation, and exclusive gender-specific solutions. A World-First Milestone in Anti-Aging Innovation As we age, mitochondrial function declines, reducing cellular energy metabolism efficiency. Alpha-ketoglutarate (AKG), a key intermediate in the tricarboxylic acid (TCA) cycle, plays a central role in energy metabolism. Endogenous AKG levels decrease with age, and supplementation may help restore cellular energy efficiency. Building on this principle, IEONA GeneAKG® explores a new approach to slowing aging at its source. Developed by the Hanmi Life Sciences team led by a Harvard-...